This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Hated Stocks Set to Soar on Earnings

Stocks in this article: ANGO OZRK NG IGTE PDLI

AngioDynamics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

My first earnings short-squeeze trade idea is medical equipment and supplies player AngioDynamics (ANGO - Get Report), which is set to report results on Thursday after the market close. This company designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors and other non-coronary diseases. Wall Street analysts, on average, expect AngioDynamics to report revenue of $52.97 million on earnings of 9 cents per share.

This company has met or beaten Wall Street estimates in the last four quarters. During the last quarter, AngioDynamics reported earnings per share of 9 cents vs. estimates of 8 cents per share. On June 24, this stock was downgraded by Canaccord Genuity from buy to hold and had its price target lowered from to $14.50 from $16.50. Canaccord said it's cautious on the stock until it sees synergies from its Navilyst acquisition.

>>5 Health Care Stocks Setting Up to Break Out

The current short interest as a percentage of the float for AngioDynamics stands at 6.5%. That means that out of the 15.12 million shares in the tradable float, 1.63 million shares are sold short by the bears. This is a decent short interest on a stock with a very low float. If AngioDynamics can manage to beat earnings estimates and raise its forward guidance, then the stock could see a solid short-squeeze post-earnings.

From a technical perspective, ANGO is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock has been trending sideways for the past three months, between $11.35 on the downside and around $12.63 on the upside. A move outside of that range post-earnings will likely setup the next major trend for ANGO.

If you're in the bull camp on ANGO, then I would wait until after it reports earnings and look for long-biased trades if this stock can manage to trigger a break out its 50-day moving average of $12.16 a share, and then above some overhead resistance at $12.55 to $12.63 a share with high-volume. Look for volume on that move that registers near or above its three-month average action of 95,083 shares. If we get that move, then ANGO has a great chance of re-testing and possibly taking out its 200-day moving average of $13.29 a share.

I would simply avoid ANGO or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops below some major near-term support at $11.71 to $11.35 a share with high-volume. If we get that action, then ANGO should easily take out its next significant support level at $11.12 a share and possibly trend much lower.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs